Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

NCT02185911 · clinicaltrials.gov ↗
COMPLETED
Status
308
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Amgen